Senior Director
City Therapeutics
Senior Director
City Therapeutics
Develops RNAi therapeutics using trigger molecules
Senior Director, Clinical Development (Medical Director)
City Therapeutics is a biotechnology company pioneering next-generation RNA interference (RNAi)-based medicines. We are building a diversified pipeline of innovative therapies through advanced RNAi trigger molecule engineering and novel targeting technologies designed to expand the reach of RNAi beyond the liver. We are seeking passionate, collaborative, and courageous individuals to join our team as we work to transform scientific discoveries into meaningful medicines for patients.
Position Overview
The Senior Director, Clinical Development (Medical Director) will provide medical and scientific leadership for City Therapeutics’ clinical development programs. This individual will play a central role in shaping clinical development strategy and translating innovative RNAi science into well-designed, executable clinical programs.
The successful candidate will serve as the medical lead for one or more programs, with responsibility for clinical strategy, protocol development, study execution, data interpretation, and regulatory interactions. This individual will collaborate closely with Clinical Operations, Biometrics, Pharmacology, Toxicology, Regulatory Affairs, Translational Medicine, and other cross-functional partners.
This is an opportunity for an experienced physician-scientist to have a meaningful impact within a growing biotechnology company and help advance programs from early clinical development through key milestones, and regulatory approvals.
Key Responsibilities
Qualifications
Location: This position is based in Cambridge, Massachusetts, and requires an onsite presence five days per week.
Equal Opportunity
City Therapeutics is an equal opportunity employer. We are committed to building an inclusive workplace and consider qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity or expression, national origin, age, disability, veteran status, genetic information, or any other characteristic protected by applicable law.
City Therapeutics is accepting resumes/CVs from direct applicants only. Recruitment Agency inquiries or submissions will not be accepted at this time.
Compensation: The base salary range provided reflects our current estimate of what we anticipate paying for this position. Your actual base salary will be based on several factors, including relevant skills, experience, internal equity, relevant education or training and market dynamics. In addition, this role is eligible for an annual cash bonus and equity compensation. City Therapeutics offers a comprehensive and competitive benefits package including medical, dental, vision, life insurance, health and dependent care FSA accounts, HSA/HRA accounts with company contributions, in addition to a 401(k) with competitive company match. Per Year Salary Range: $255,000 to $290,000
Develops RNAi therapeutics using trigger molecules
City Therapeutics develops RNA interference (RNAi) medicines. It works on creating next-generation trigger molecules and delivery ligands to silence disease-causing genes in the body. The core product approach uses RNAi to turn off specific genes in cells, reducing the production of harmful proteins. Delivery and targeting are tailored, so the RNAi triggers reach the right tissues more effectively than before. Compared with peers, City Therapeutics emphasizes proprietary trigger chemistry and ligand-based delivery to improve precision and expand the range of diseases that can be treated, aiming for strong therapeutic impact rather than relying on traditional small molecules or antibodies. The company’s goal is to advance and apply RNAi-based medicines across multiple conditions by leveraging human genetics insights, partnerships, and focused development to bring effective gene-silencing therapies to patients.
Explore more opportunities at City Therapeutics